Portfolio company Disc Medicine presents positive initial data from Phase 2 BEACON trial at EHA
Portfolio company Disc Medicine presents positive initial data from Phase 2 BEACON trial at EHA
Source: sharewise.com
📰 John Quisel News
Page 3 - John Quisel News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from John Quisel. Real-time updates on events, politics, business and more.
Disc Medicine Opco : Reports First Quarter 2023 Financial Results and Provides Business Update - Form 8-K
Disc Medicine, Inc. , a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic... | May 15, 2023
Suzanne Messere John Quisel Exchange Commission Verge Scientific Communications Congress On European Hematology Association
Source: marketscreener.com
Disc Medicine Opco : Reports Full Year 2022 Financial Results and Provides Business Update - Form 8-K
Disc Medicine, Inc. , a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic... | March 31, 2023
United States Suzanne Messere Arix Bioscience John Quisel European Committee For Orphan Medical Products Novo Holdings
Source: marketscreener.com
Investegate |Arix Bioscience PLC Announcements | Arix Bioscience PLC: Portfolio company Disc Medicine announces $62.5 million financing
Investegate announcements from Arix Bioscience PLC, Portfolio company Disc Medicine announces $62.5 million financing
Source: investegate.co.uk
Investegate |Arix Bioscience PLC Announcements | Arix Bioscience PLC: Portfolio Company Disc Medicine Completes Merger with Gemini Therapeutics
Investegate announcements from Arix Bioscience PLC, Portfolio Company Disc Medicine Completes Merger with Gemini Therapeutics
Source: investegate.co.uk
Disc Medicine Announces Completion of Merger with Gemini
The combined company will operate as Disc Medicine and will trade on the Nasdaq Global Market under the ticker symbol “IRON”Approximately $175 million of...
Wedbush Pacgrow Wilmer Cutler Pickering Hale Arix Bioscience John Quisel Morgan Stanley Disc Medicine Inc
Source: globenewswire.com
Disc Medicine Receives FDA Orphan Drug Designation for Bitopertin for the Treatment of Erythropoietic Protoporphyria
/PRNewswire/ -- Disc Medicine, Inc. ("Disc"), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel...
United States John Quisel Gemini Therapeutics Inc Drug Administration Disc Medicine Inc Prnewswire Disc Medicine Inc
Source: prnewswire.com
Bitopertin Granted Orphan Drug Status for Erythropoietic Protoporphyria
The FDA has granted Orphan Drug designation to bitopertin for the treatment of erythropoietic protoporphyria.
Source: empr.com
Disc Medicine Initiates AURORA, a Phase 2 Clinical Study of Bitopertin in Adults with Erythropoietic Protoporphyria (EPP)
/PRNewswire/ -- Disc Medicine, a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel treatments for...
United States John Quisel Gemini Therapeutics Inc University Of Miami Miller School Medicine Chief Executive Officer Cynthia Levy
Source: prnewswire.com
Gemini enters business combination deal with Disc Medicine
Gemini Therapeutics signed an agreement to merge with Disc Medicine in an all-stock deal to create a clinical-stage biopharmaceutical firm.
United States Arek Socha John Quisel Tablet Compression Tooling Solutions For Pharmaceutical Applications Atlas Venture Disc Medicine
Source: pharmaceutical-technology.com